Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

ConditionsGastric Cancer (GC)HIPEC Peritoneal Metastases From Gastric Cancer Hyperthermic Intraperitoneal Chemoperfusion

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-80

SponsorUkrainian Society of Clinical Oncology

About this trial

The study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.

Eligibility criteria

Qualifiers

Age 18-80

Hystologicaly proven gastric adenocarcinoma

ECOG status 0-1

Written consent to participate in the study

Disqualifiers

Pregnancy/breastfeeding

ECOG status 2-4

Concomitant malignancy

Mitomycin and/or Cisplatin hypersensitivity

Trial design

Treatments tested in this trial

curative-intent surgery + HIPEC

Treatment groups

200 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Ukrainian Society of Clinical Oncology

Lead sponsor

Source ClinicalTrials.gov